Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 2/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.58 |
| ▸ | LMNA | P02545 | 4/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | CES2 | O00748 | 1/20 | 0.50 |
| ▸ | CES1 | P23141 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | ELANE | P08246 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | MGLL | Q99685 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.43 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.43 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.43 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2246434 | 1.00 | ATM (0.58) | ATML3MBTL1LMNAMAPK1CES2 | |
| SCHEMBL11119110 | 1.00 | ATM (0.58) | ATML3MBTL1LMNAMAPK1CES2 | |
| SCHEMBL8715340 | 0.89 | LMNA (0.48) | ATML3MBTL1LMNAMAPK1CES2 | |
| SCHEMBL8715341 | 0.89 | LMNA (0.48) | ATML3MBTL1LMNAMAPK1CES2 | |
| SCHEMBL14166103 | 0.86 | LMNA (0.46) | ATML3MBTL1LMNAMAPK1CES2 | |
| SCHEMBL27652140 | 0.83 | MAPT (0.58) | ATML3MBTL1LMNAMAPK1ELANE | |
| SCHEMBL9305068 | 0.82 | ALDH1A1 (0.50) | ATML3MBTL1LMNAMAPK1CES2 | |
| SCHEMBL9305059 | 0.82 | ALDH1A1 (0.50) | ATML3MBTL1LMNAMAPK1CES2 | |
| SCHEMBL6075641 | 0.82 | LMNA (0.46) | ATML3MBTL1LMNAMAPK1CES2 | |
| SCHEMBL14166147 | 0.82 | L3MBTL1 (0.42) | ATML3MBTL1LMNAMAPK1CES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250346553-A1 | Process for the Preparation of R-Oxybutynin Hydrochloride | HARMAN FINOCHEM LTD (IN) | 2025-11-13 | — | — | US | disclosed |
| EP-4519242-A1 | PROCESS FOR THE PREPARATION OF R-OXYBUTYNIN HYDROCHLORIDE | Harman Finochem Limited (IN) | 2025-03-12 | — | — | EP | disclosed |
| CN-118063305-A | Method for synthesizing 2-cyclohexyl-2-hydroxyphenylacetic acid through continuous flow | 深圳智微通科技有限公司 | 2024-05-24 | — | — | CN | disclosed |
| WO-2023214426-A1 | PROCESS FOR THE PREPARATION OF R-OXYBUTYNIN HYDROCHLORIDE | HARMAN FINOCHEM LIMITED (IN) | 2023-11-09 | — | — | WO | disclosed |
| CN-110381934-A | L-PAG derivatives for the treatment of Sleep Disordered Breathing (SDB) | 芝加哥大学 | 2019-10-25 | — | — | CN | disclosed |
| CN-107089912-A | A kind of method that metallocene complex selective catalysis synthesizes mandelic acid ester type compound | 湖南大学 | 2017-08-25 | — | — | CN | disclosed |
| CN-103562198-B | There is muscarinic receptor antagonist and the compound of beta 2-adrenergic receptor agonists activity | 奇斯药制品公司 | 2016-08-24 | — | — | CN | disclosed |
| EP-1424321-B1 | Synthesis of optically active cyclohexylphenylglycolate esters | SEPRACOR INC (US) | 2006-07-05 | — | — | EP | disclosed |
| EP-1642883-A2 | Optically active cyclohexylphenylglycolate esters | SEPRACOR Inc (US) | 2006-04-05 | — | — | EP | disclosed |
| EP-1424321-A1 | Synthesis of optically active cyclohexylphenylglycolate esters | Sepracor, Inc. (US) | 2004-06-02 | — | — | EP | disclosed |
| US-6087465-A | POLYESTERURETHANE COPOLYMERS FOR MELTS | VALTION TEKNILLINEN TUTKIMUSKESKUS (FI) | 2000-07-11 | — | — | US | disclosed |
| WO-2000027786-A1 | STEREOSELECTIVE PROCESS FOR PREPARING (CYCLO)ALKYL PHENYLGLYCOLIC ACIDS | SEPRACOR INC. (US) | 2000-05-18 | — | — | WO | disclosed |
| WO-2000023414-A2 | SYNTHESIS OF OPTICALLY ACTIVE CYCLOHEXYLPHENYLGLYCOLIC ACID AND ITS ESTERS | SEPRACOR INC. (US) | 2000-04-27 | — | — | WO | disclosed |
| US-6025177-A | ENANTIOSELECTIVE SYNTHESIS OF CHIRAL ALPHA-HYDROXYCARBOXYLATE BY REACTING A PROCHIRAL ALPHA-KETOCARBOXYLIC ACID WITH A SINGLE ENANTIOMER OF AN N-SUBSTITUTED VICINAL AMINOALCOHOL OF SPECIFIC CYCLOHYDROCARBONS TO FORM ALPHA-HYDROXYCARBOXYLATE | SEPRACOR INC. (US) | 2000-02-15 | — | — | US | disclosed |
| US-6013830-A | CHEMICAL INTERMEDIATES FOR OXYBUTYNIN, OXYPHENCYCLIMINE, OXYPHENONIUM BROMIDE, OXYPYRRONIUM BROMIDE, AND OXYSONIUM IODIDE, FOR WHICH CYCLOHEXYLPHENYLGLYCOLIC ACID (CHPGA) IS OF SPECIAL INTEREST; STEREOSELECTIVITY | SEPRACOR INC. (US) | 2000-01-11 | — | — | US | disclosed |
| US-5973182-A | Carbonate Intermediates useful in the preparation of optically active cyclohexylphenylglycolate esters | SEPRACOR INC. (US) | 1999-10-26 | — | — | US | disclosed |
| WO-1999050205-A2 | ASYMMETRIC GRIGNARD SYNTHESIS WITH CYCLIC 1,2 AMINOALCOHOLS | SEPRACOR INC. (US) | 1999-10-07 | — | — | WO | disclosed |
| EP-0746551-A1 | OPTICALLY PURE 4-ARYL-2-HYDROXYTETRONIC ACIDS | THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 1996-12-11 | — | — | EP | disclosed |
| EP-0056271-B1 | CARBOXYLIC ACID ESTERS AND INSECTICIDAL AND/OR ACARICIDAL COMPOSITIONS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1986-05-07 | — | — | EP | disclosed |
| EP-0056271-A2 | Carboxylic acid esters and insecticidal and/or acaricidal compositions | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1982-07-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250346553-A1 | Process for the Preparation of R-Oxybutynin Hydrochloride | GCG, GRHPR, CYP8B1 | ATM 4839/4885L3MBTL1 4646/4885LMNA 1055/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.